OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms
Murray Epstein, Csaba P. Kövesdy, Catherine M. Clase, et al.
American Journal of Kidney Diseases (2022) Vol. 80, Iss. 5, pp. 658-666
Open Access | Times Cited: 48
Murray Epstein, Csaba P. Kövesdy, Catherine M. Clase, et al.
American Journal of Kidney Diseases (2022) Vol. 80, Iss. 5, pp. 658-666
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Diabetic Kidney Disease
Sonali Gupta, Mary Dominguez, Ladan Golestaneh
Medical Clinics of North America (2023) Vol. 107, Iss. 4, pp. 689-705
Closed Access | Times Cited: 115
Sonali Gupta, Mary Dominguez, Ladan Golestaneh
Medical Clinics of North America (2023) Vol. 107, Iss. 4, pp. 689-705
Closed Access | Times Cited: 115
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, et al.
The Lancet (2023) Vol. 403, Iss. 10424, pp. 379-390
Open Access | Times Cited: 67
Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, et al.
The Lancet (2023) Vol. 403, Iss. 10424, pp. 379-390
Open Access | Times Cited: 67
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 29
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 29
Advances in the management of chronic kidney disease
Teresa K. Chen, Melanie P. Hoenig, Dorothea Nitsch, et al.
BMJ (2023), pp. e074216-e074216
Open Access | Times Cited: 27
Teresa K. Chen, Melanie P. Hoenig, Dorothea Nitsch, et al.
BMJ (2023), pp. e074216-e074216
Open Access | Times Cited: 27
Management of chronic kidney disease: The current novel and forgotten therapies
Ákos Pethő, Mihály Tapolyai, Éva Csongrádi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100354-100354
Open Access | Times Cited: 8
Ákos Pethő, Mihály Tapolyai, Éva Csongrádi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100354-100354
Open Access | Times Cited: 8
The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes
David S.H. Bell, Terri Jerkins
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2046-2053
Closed Access | Times Cited: 7
David S.H. Bell, Terri Jerkins
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2046-2053
Closed Access | Times Cited: 7
Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease
Donald E. Kohan, Patricia W. Bedard, Celia Jenkinson, et al.
Clinical Science (2024) Vol. 138, Iss. 11, pp. 645-662
Open Access | Times Cited: 7
Donald E. Kohan, Patricia W. Bedard, Celia Jenkinson, et al.
Clinical Science (2024) Vol. 138, Iss. 11, pp. 645-662
Open Access | Times Cited: 7
Use of bailing capsules (cordyceps sinensis) in the treatment of chronic kidney disease: a meta-analysis and network pharmacology
Yilin Tao, Ruixiang Luo, Yuanbing Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Yilin Tao, Ruixiang Luo, Yuanbing Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Parminder K. Judge, Katherine R. Tuttle, Natalie Staplin, et al.
Nephrology Dialysis Transplantation (2024)
Open Access | Times Cited: 4
Parminder K. Judge, Katherine R. Tuttle, Natalie Staplin, et al.
Nephrology Dialysis Transplantation (2024)
Open Access | Times Cited: 4
Saudi Consensus Report on Chronic Kidney Disease Management: Integrating the Latest Evidence and Clinical Practice Guidelines
Abdulrahman Alsheikh, Ahmed Al‐Jedai, Hajer Almudaiheem, et al.
International Journal of Clinical Medicine (2025) Vol. 16, Iss. 01, pp. 54-88
Open Access
Abdulrahman Alsheikh, Ahmed Al‐Jedai, Hajer Almudaiheem, et al.
International Journal of Clinical Medicine (2025) Vol. 16, Iss. 01, pp. 54-88
Open Access
Advances and challenges in kidney fibrosis therapeutics
Lilia Abbad, Emmanuel Estève, Christos Chatziantoniou
Nature Reviews Nephrology (2025)
Closed Access
Lilia Abbad, Emmanuel Estève, Christos Chatziantoniou
Nature Reviews Nephrology (2025)
Closed Access
Water and electrolyte abnormalities in novel pharmacological agents for kidney disease and cancer
Maho Terashita, Masahiko Yazawa, Naoka Murakami, et al.
Clinical and Experimental Nephrology (2025)
Open Access
Maho Terashita, Masahiko Yazawa, Naoka Murakami, et al.
Clinical and Experimental Nephrology (2025)
Open Access
Guideline-Directed Medical Therapy for Heart Failure in Transthyretin Amyloid Cardiomyopathy
Stéphanie K. Schwarting, Thomas Bieber, Daniel R. Davies, et al.
Circulation Heart Failure (2025)
Closed Access
Stéphanie K. Schwarting, Thomas Bieber, Daniel R. Davies, et al.
Circulation Heart Failure (2025)
Closed Access
Development of mass spectrometric methods for determination of desoxycorticosterone pivalate and its esterase product in canine serum
Andreas F. Lehner, Justin Zyskowski, John P. Buchweitz, et al.
Toxicology Mechanisms and Methods (2025), pp. 1-13
Open Access
Andreas F. Lehner, Justin Zyskowski, John P. Buchweitz, et al.
Toxicology Mechanisms and Methods (2025), pp. 1-13
Open Access
Coenzyme Q10 alleviates oxidative stress, inflammation and fibrosis via activation of TGFβ1/TNF-α in FCA-Salt hypertensive rats
Nusrat Hossain, S Shabnam, Tushar Emran, et al.
Archives of Biochemistry and Biophysics (2025) Vol. 769, pp. 110444-110444
Closed Access
Nusrat Hossain, S Shabnam, Tushar Emran, et al.
Archives of Biochemistry and Biophysics (2025) Vol. 769, pp. 110444-110444
Closed Access
Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management
Debbie L. Cohen, Heather Wachtel, Anand Vaidya, et al.
Hypertension (2023) Vol. 80, Iss. 10, pp. 2187-2195
Closed Access | Times Cited: 10
Debbie L. Cohen, Heather Wachtel, Anand Vaidya, et al.
Hypertension (2023) Vol. 80, Iss. 10, pp. 2187-2195
Closed Access | Times Cited: 10
Inhibition of aldosterone synthase: Does this offer advantages compared with the blockade of mineralocorticoid receptors?
Hitoshi Ando
Hypertension Research (2023) Vol. 46, Iss. 4, pp. 1056-1057
Open Access | Times Cited: 9
Hitoshi Ando
Hypertension Research (2023) Vol. 46, Iss. 4, pp. 1056-1057
Open Access | Times Cited: 9
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease
Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 869-869
Open Access | Times Cited: 3
Shinji Hagiwara, Tomohito Gohda, Phillip Kantharidis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 869-869
Open Access | Times Cited: 3
A New Hope on the Horizon for Kidney and Cardiovascular Protection with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists in Type 2 Diabetic and Chronic Kidney Disease Patients
Goce Spasovski, Merita Rroji, G. Hristov, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 3, pp. 170-178
Closed Access | Times Cited: 3
Goce Spasovski, Merita Rroji, G. Hristov, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 3, pp. 170-178
Closed Access | Times Cited: 3
Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses
Jinbo Hu, Xiangjun Chen, Yixin Luo, et al.
Metabolism (2023) Vol. 145, pp. 155593-155593
Closed Access | Times Cited: 8
Jinbo Hu, Xiangjun Chen, Yixin Luo, et al.
Metabolism (2023) Vol. 145, pp. 155593-155593
Closed Access | Times Cited: 8
A biomimetic renal fibrosis progression model on-chip evaluates anti-fibrotic effects longitudinally in a dynamic fibrogenic niche
Di Wu, Jianguo Wu, Hui Liu, et al.
Lab on a Chip (2023) Vol. 23, Iss. 21, pp. 4708-4725
Closed Access | Times Cited: 7
Di Wu, Jianguo Wu, Hui Liu, et al.
Lab on a Chip (2023) Vol. 23, Iss. 21, pp. 4708-4725
Closed Access | Times Cited: 7
Role of inflammation in the progression of diabetic kidney disease
Arunita Chatterjee, Jacqueline Tumarin, Sharma Prabhakar
Vessel Plus (2024)
Open Access | Times Cited: 2
Arunita Chatterjee, Jacqueline Tumarin, Sharma Prabhakar
Vessel Plus (2024)
Open Access | Times Cited: 2
Fabry nephropathy: a treatable cause of chronic kidney disease
Michael L. West, Laurette Geldenhuys, Daniel G. Bichet
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 2
Michael L. West, Laurette Geldenhuys, Daniel G. Bichet
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 2
Elucidating the complex interplay between chronic kidney disease and hypertension
Daisuke Nagata, Erika Hishida
Hypertension Research (2024)
Closed Access | Times Cited: 2
Daisuke Nagata, Erika Hishida
Hypertension Research (2024)
Closed Access | Times Cited: 2
Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach
Lucas Salgado Rezende de Mendonça, Sergio Senar, Luana Lorena Moreira, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108124-108124
Closed Access | Times Cited: 1
Lucas Salgado Rezende de Mendonça, Sergio Senar, Luana Lorena Moreira, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108124-108124
Closed Access | Times Cited: 1
